@Article{Lamparski2026,
journal="Gastroenterology Review/Przegląd Gastroenterologiczny",
issn="1895-5770",
year="2026",
title="Multicentre retrospective real-world evidence
study\ evaluating the effectiveness and safety of mirikizumab in
patients with moderately to severely active ulcerative colitis",
author="Lamparski, Łukasz
and Karłowicz, Katarzyna
and Tulewicz-Marti, Edyta
and Mahadea, Dagmara
and Łykowska-Szuber, Liliana
and Sarbinowska, Joanna
and Gonciarz, Maciej
and Kabała, Bartosz
and Szkudłapski, Dawid
and Zawada, Iwona
and Tarnowska, Maria
and Sójka, Aleksandra
and Neubauer, Katarzyna
and Stojek, Magdalena
and Adrych, Krystian
and Romańczyk, Tomasz
and Romańczyk, Marcin
and Chaber-Ciopińska, Anna
and Zagórowicz, Edyta
and Michalak, Agata
and Cichoż-Lach, Halina
and Domżał-Magrowska, Danuta
and Boduła, Anna
and Małecka-Wojciesko, Ewa
and Walecka-Kapica, Ewa
and Gąsiorowska, Anita
and Pietraszek, Agnieszka
and Pol, Krzysztof
and Nemeczek, Sylwia
and Filip, Agata
and Gawron-Kiszka, Magdalena
and Musialik, Joanna
and Klufczyńska, Agnieszka
and Piotrowicz, Grazyna
and Pietrzak, Anna
and Zwolińska-Wcisło, Małgorzata
and Daniluk, Jarosław
and Kopertowska-Majchrzak, Maria
and Koza, Jarosław
and Kłopocka, Maria
and Rydzewska, Grazyna
and Lewandowski, Konrad",
doi="10.5114/pg.2026.161906",
url="http://dx.doi.org/10.5114/pg.2026.161906"
}